Biotech · Private company
DNAtrix, Inc.
Track this companyFree. Adds DNAtrix, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- DNX-2401Phase 2 · Brain CancerClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · Brain CancerClinicalTrials.gov · fetched Nov 12, 2026
- DNX-2440Phase 1 · Liver MetastasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- DNX-2440 for Resectable Colorectal Liver MetastasisPHASE1 · SUSPENDED · started Feb 15, 2021ClinicalTrials.gov NCT04714983 · fetched Nov 12, 2026
- MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaPHASE1 · RECRUITING · started Feb 12, 2019ClinicalTrials.gov NCT03896568 · fetched Nov 12, 2026
- Combination Adenovirus + Pembrolizumab to Trigger Immune Virus EffectsPHASE2 · COMPLETED · started Oct 6, 2016ClinicalTrials.gov NCT02798406 · fetched Nov 12, 2026